{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:37:15Z","timestamp":1782293835879,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"The Joint Science & Technology Office for Chemical & Biological Defense","award":["CB10204"],"award-info":[{"award-number":["CB10204"]}]},{"name":"The Joint Science & Technology Office for Chemical & Biological Defense","award":["CB10204"],"award-info":[{"award-number":["CB10204"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.antiviral.2018.09.014","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T13:42:48Z","timestamp":1538055768000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice"],"prefix":"10.1016","volume":"159","author":[{"given":"John J.","family":"Suschak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-8279","authenticated-orcid":false,"given":"Kenneth","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Six","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-3879","authenticated-orcid":false,"given":"Steven","family":"Kwilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin W.","family":"Spik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley C.","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie S.","family":"Schmaljohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.09.014_bib1","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1080\/21645515.2015.1026498","article-title":"The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1\/Th17 cellular immune responses","volume":"11","author":"Bagley","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.09.014_bib2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/CVI.05019-11","article-title":"Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun","volume":"18","author":"Bagley","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/vim.2016.0136","article-title":"An interleukin 12 adjuvanted herpes simplex virus 2 DNA vaccine is more protective than a glycoprotein D subunit vaccine in a high-dose murine challenge model","volume":"30","author":"Bagley","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0264-410X(00)00123-7","article-title":"An immunological profile of Balb\/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine","volume":"19","author":"Bennett","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0684.2005.00124.x","article-title":"SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques","volume":"34","author":"Boyer","year":"2005","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0264-410X(02)00694-1","article-title":"Super-activated interferon-regulatory factors can enhance plasmid immunization","volume":"21","author":"Bramson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib7","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1128\/JVI.02545-09","article-title":"T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody","volume":"84","author":"Brooke","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1078-0432.CCR-06-2039","article-title":"A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients","volume":"13","author":"Cassaday","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.antiviral.2018.09.014_bib9","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.vaccine.2015.03.093","article-title":"Adjuvant activity of fish type I interferon shown in a virus DNA vaccination model","volume":"33","author":"Chang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2014.08.005","article-title":"Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice","volume":"162","author":"Chen","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2018.09.014_bib11","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1016\/j.vaccine.2006.11.070","article-title":"Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques","volume":"25","author":"Chong","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/am.25.2.262-265.1973","article-title":"Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells","volume":"25","author":"Cole","year":"1973","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm1096-1122","article-title":"DNA-based immunization by in vivo transfection of dendritic cells","volume":"2","author":"Condon","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.09.014_bib13","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2009.04.049","article-title":"Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine","volume":"27","author":"Dupuy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"Dupuy","year":"2011","journal-title":"Clin. Vaccine Immunol.: CVI"},{"key":"10.1016\/j.antiviral.2018.09.014_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8521060","volume":"2018","author":"Dupuy","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.antiviral.2018.09.014_bib16","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1016\/j.vaccine.2010.09.005","article-title":"Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates","volume":"28","author":"Dupuy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib17","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1016\/j.vaccine.2005.08.024","article-title":"Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice","volume":"24","author":"Egan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01274-17","article-title":"Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge","volume":"92","author":"Erasmus","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-2712(18)30018-0","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"21","author":"Franz","year":"2001","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.antiviral.2018.09.014_bib20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.09.014_bib21","doi-asserted-by":"crossref","first-page":"e2197","DOI":"10.1371\/journal.pntd.0002197","article-title":"IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety","volume":"7","author":"Guerbois","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2018.09.014_bib22","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.4049\/jimmunol.180.12.7969","article-title":"Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques","volume":"180","author":"Halwani","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib23","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2016.04.077","article-title":"A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation","volume":"34","author":"Hannaman","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","article-title":"Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards","volume":"158","author":"Hanson","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.09.014_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0264-410X(96)00204-6","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB\/c, but not C3H\/HeN mice","volume":"15","author":"Hart","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/21645515.2015.1082692","article-title":"Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice","volume":"12","author":"Hou","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.09.014_bib27","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2018.06.064","article-title":"Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses","volume":"36","author":"Hu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines","volume":"451","author":"Ishii","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.09.014_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"Kalams","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2018.09.014_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"J. infect. Diseases"},{"key":"10.1016\/j.antiviral.2018.09.014_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/107999099314441","article-title":"Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV","volume":"19","author":"Kim","year":"1999","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interf. Cytokine Res."},{"key":"10.1016\/j.antiviral.2018.09.014_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/10799900050023906","article-title":"Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines","volume":"20","author":"Kim","year":"2000","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interf. Cytokine Res."},{"key":"10.1016\/j.antiviral.2018.09.014_bib33","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/JVI.00055-07","article-title":"Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques","volume":"81","author":"Luckay","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib34","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells","volume":"161","author":"Luft","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1089\/vim.2014.0071","article-title":"Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein","volume":"28","author":"Martins","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.1963.12.597","article-title":"Use of an attenuated strain of venezuelan equine encephalomyelitis virus for immunization in man","volume":"12","author":"McKinney","year":"1963","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2018.09.014_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01729-16","article-title":"Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single-dose protection against lethal alphavirus challenge","volume":"91","author":"Nasar","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib38","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1099\/vir.0.006833-0","article-title":"Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection","volume":"90","author":"O'Brien","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib39","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J. Virol."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2018.09.014_bib40","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2007.05.041","article-title":"Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection","volume":"367","author":"Paessler","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.09.014_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib43","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.188.6.1075","article-title":"Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization","volume":"188","author":"Porgador","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2018.09.014_bib44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib45","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1128\/JVI.01406-14","article-title":"Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses","volume":"88","author":"Reed","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib46","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0684.2007.00245.x","article-title":"Macaques co-immunized with SIVgag\/pol-HIVenv and IL-12 plasmid have increased cellular responses","volume":"36","author":"Robinson","year":"2007","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1590\/0074-02760150283","article-title":"Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses","volume":"110","author":"Santana","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.antiviral.2018.09.014_bib49","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1128\/JVI.76.13.6652-6659.2002","article-title":"Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors","volume":"76","author":"Sasaki","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.09.014_bib51","series-title":"Medical Aspects of Biological Warfare","first-page":"241","author":"Steele","year":"2007"},{"key":"10.1016\/j.antiviral.2018.09.014_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy378","article-title":"The genetic adjuvants Interleukin-12 and granulocyte-macrophage colony stimulating factor enhance the immunogenicity of an Ebola virus deoxyribonucleic acid vaccine in mice","author":"Suschak","year":"2018","journal-title":"J. infect. Diseases"},{"key":"10.1016\/j.antiviral.2018.09.014_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.1501836","article-title":"A cGAS-independent STING\/IRF7 pathway mediates the immunogenicity of DNA vaccines","volume":"196","author":"Suschak","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.09.014_bib54","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2012.12.050","article-title":"Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine","volume":"31","author":"Tretyakova","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.09.014_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0891-5520(20)30389-5","article-title":"Arboviral infections in the United States","volume":"5","author":"Tsai","year":"1991","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.antiviral.2018.09.014_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.2001.0957","article-title":"Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C","volume":"286","author":"Tudor","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.09.014_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1074-7613(95)80001-8","article-title":"Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines","volume":"2","author":"Xiang","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2018.09.014_bib58","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:47Z","timestamp":1759062467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":59,"alternative-id":["S0166354218303784"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}